Masato Obara
About
Masato Obara is a scholar working on Hematology, Genetics and Immunology.
According to data from OpenAlex, Masato Obara has authored 20 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Genetics and 5 papers in Immunology. Recurrent topics in Masato Obara's work include Chronic Lymphocytic Leukemia Research (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Masato Obara is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Masato Obara collaborates with scholars based in Japan, United States and Italy. Masato Obara's co-authors include Tomoyuki Endo, Katsuya Fujimoto, Takao Koike, Mitsufumi Nishio, Norihiro Sato, Yukari Takeda, Keisuke Yamaguchi, Motohide Nishio, Satoshi Yamamoto and Koichiro Minauchi and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and The American Journal of Cardiology.
In The Last Decade
Masato Obara
17 papers receiving 296 citations
Peers
Masato Obara
Luděk Raida Czechia
Elizabeth L. Courville United States
Maria Arroz Portugal
Jeremy Ramdial United States
Tadaharu Kanie Japan
Meghan A. Higman United States
Marion Eveillard France
Marguerite Vignon France
Dag Heldal Norway
Fábio R. Kerbauy Brazil
Citations per year, relative to Masato Obara Masato Obara (= 1×)
peers
Luděk Raida
Countries citing papers authored by Masato Obara
Since
Specialization
Citations
This map shows the geographic impact of Masato Obara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Obara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Obara more than expected).
Fields of papers citing papers by Masato Obara
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Masato Obara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Obara. The network helps show where Masato Obara may publish in the future.
Co-authorship network of co-authors of Masato Obara
This figure shows the co-authorship network connecting the top 25 collaborators of Masato Obara. A scholar is included among the top collaborators of Masato Obara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Obara. Masato Obara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Obara, Masato, et al.. (2025). The Efficacy of Hemostatic Agents on Radial Artery Compression Methods Following Transradial Procedures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The American Journal of Cardiology. 258. 210–217.
2.
Obara, Masato, et al.. (2016). An STD System Using Multiple STD Results and Multiple Rescoring Method for NTCIR-12 SpokenQuery&Doc Task.. NTCIR.
3.
Obara, Masato, et al.. (2016). Rescoring by Combination of Posteriorgram Score and Subword-Matching Score for Use in Query-by-Example. 1918–1922.
4.
Minauchi, Koichiro, Takahide Ara, Atsushi Yasumoto, et al.. (2015). [Serum ALP elevation early after treatment is a predictor for response in myeloma patients treated with bortezomib].. PubMed. 56(8). 1064–8.
5.
Minauchi, Koichiro, Masato Obara, Takahide Ara, et al.. (2013). Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience. Blood. 122(21). 2697–2697.
6.
Widhopf, George F., Bing Cui, Esther Avery, et al.. (2011). ROR1 Expression Accelerates Leukemia Development in RORxTCL1 Transgenic Mice,. Blood. 118(21). 3905–3905.
7.
Sugita, Junichi, T. Matsushita, Hiroshi Kashiwazaki, et al.. (2011). Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD. Bone Marrow Transplantation. 47(2). 258–264.
8.
Nishihara, Hiroshi, Taichi Kimura, Yasutaka Kato, et al.. (2010). DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma. Biochemical and Biophysical Research Communications. 395(1). 111–115.
9.
Endo, Tomoyuki, Katsuya Fujimoto, Mitsufumi Nishio, et al.. (2009). Case report: Clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus. Journal of Medical Virology. 81(6). 979–982.
10.
Fujimoto, Katsuya, Tomoyuki Endo, Mitsufumi Nishio, et al.. (2009). Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier. International Journal of Hematology. 90(5). 601–604.
11.
Nishio, Mitsufumi, Tomoyuki Endo, Katsuya Fujimoto, et al.. (2008). FCGR3A‐158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non‐Hodgkin’s lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. European Journal Of Haematology. 82(2). 143–147.
12.
Shigematsu, Akio, Takeshi Kondo, Satoshi Yamamoto, et al.. (2008). Excellent Outcome of Allogeneic Hematopoietic Stem Cell Transplantation Using a Conditioning Regimen with Medium-Dose VP-16, Cyclophosphamide and Total-Body Irradiation for Adult Patients with Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 14(5). 568–575.
13.
Nishio, Mitsufumi, Tomoyuki Endo, Katsuya Fujimoto, et al.. (2008). FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.. Blood. 112(11). 3245–3245.
14.
Nishio, Mitsufumi, Katsuya Fujimoto, Satoshi Yamamoto, et al.. (2007). Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non‐Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. British Journal of Haematology. 137(4). 349–354.
15.
Nishio, Mitsufumi, Katsuya Fujimoto, Satoshi Yamamoto, et al.. (2006). Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non‐Hodgkin lymphoma. European Journal Of Haematology. 77(3). 226–232.
16.
Shigemura, Masahiko, Takanori Moriyama, Hitoshi Shibuya, et al.. (2006). Multiple myeloma associated with sialyl salivary-type amylase. Clinica Chimica Acta. 376(1-2). 121–125.
17.
Goto, Hideko, Motohide Nishio, Tomoyuki Endo, et al.. (2005). Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B‐cell lymphoma. European Journal Of Haematology. 74(6). 526–528.
18.
Endo, Tomoyuki, Norihiro Sato, K Koizumi, et al.. (2004). Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma. Bone Marrow Transplantation. 33(7). 703–707.
19.
Endo, Tomoyuki, Norihiro Sato, K Koizumi, et al.. (2004). Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia. American Journal of Hematology. 76(3). 279–282.
20.
Endo, Tomoyuki, Shinji Nakao, K Koizumi, et al.. (2004). Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient. Annals of Hematology. 83(2). 114–116.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Luděk Raida Breakdown of academic impact, for papers by Elizabeth L. Courville Breakdown of academic impact, for papers by Maria Arroz Breakdown of academic impact, for papers by Jeremy Ramdial Breakdown of academic impact, for papers by Tadaharu Kanie Breakdown of academic impact, for papers by Meghan A. Higman Breakdown of academic impact, for papers by Marion Eveillard Breakdown of academic impact, for papers by Marguerite Vignon Breakdown of academic impact, for papers by Dag Heldal Breakdown of academic impact, for papers by Fábio R. Kerbauy